REQUEST A DEMO
Total
USD $0.00
Search more companies

Hexun Biosciences Co. Ltd. (Taiwan, China)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Hexun Biosciences Co. Ltd. Profile Updated: February 12, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Hexun Biosciences Co. Ltd. is a company based in Taiwan, China, with its head office in Taoyuan City. It operates in the Pharmaceutical Preparation Manufacturing sector. Hexun Biosciences Co. Ltd. was incorporated on April 12, 2026. The total number of employees is currently 51 (2024). In its most recent financial highlights, the company reported a net sales revenue increase of 13.52% in Q2C2025. Its total assets grew by 28.07% over the same period. The net profit margin of Hexun Biosciences Co. Ltd. decreased by 17.4% in 2025.

Headquarters
6 F., No. 1490, Chunri Rd, Taoyuan Dist
Taoyuan City; Taoyuan City;

Contact Details: Purchase the Hexun Biosciences Co. Ltd. report to view the information.

Website: http://www.hexunbio.com

Basic Information
Total Employees:
Purchase the Hexun Biosciences Co. Ltd. report to view the information.
Outstanding Shares:
Purchase the Hexun Biosciences Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Hexun Biosciences Co. Ltd. report to view the information.
Incorporation Date:
April 12, 2026
Key Executives
Purchase this report to view the information.
Chairman
Ownership Details
Purchase this report to view the information.
8.86%
Purchase this report to view the information.
8.09%
Purchase this report to view the information.
6.53%
Purchase this report to view the information.
4.96%
Purchase this report to view the information.
4.57%
Company Performance
Financial values in the chart are available after Hexun Biosciences Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
13.52%
Total Operating Revenue
13.11%
Operating Profit
-5.11%
EBITDA
-0.8%
Net Profit/Loss for the Period
-20.59%
Total Assets
28.07%
Total Equity
24.59%
Operating Profit Margin
-9.27%
Net Profit Margin
-17.4%
Return on Equity (ROE)
-5.09%
Debt / Equity
-1159%
Quick Ratio
-4312.07%
Cash Ratio
-3.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?